Flammer syndrome

EPMA Journal

Volumn 5, Issue 1, 2014, Pages

  Konieczka, Katarzyna ^a   Ritch, Robert ^b   Traverso, Carlo E ^c   Kim, Dong M ^d   Kook, Michael S ^e   Gallino, Augusto ^f   Golubnitschaja, Olga ^g   Erb, Carl ^h   Reitsamer, Herbert A ⁱ   Kida, Teruyo ^j   Kurysheva, Natalia ^k   Yao, Ke ^l  

^a UNIVERSITY OF BASEL   (Switzerland)

^b NEW YORK EYE AND EAR INFIRMARY   (United States)

^c UNIVERSITY OF GENOA   (Italy)

^d Seoul National University   (South Korea)

^e University of Ulsan   (South Korea)

^f OSPEDALE SAN GIOVANNI   (Switzerland)

^g UNIVERSITY OF BONN   (Germany)

^h Wittenbergplatz Hospital   (Germany)

ⁱ PARACELSUS MEDICAL UNIVERSITY   (Austria)

^j OSAKA MEDICAL COLLEGE   (Japan)

^k Institute of Physico Chemical Medicine Federal Medical Biological Agency of the Russian Federation   (Russian Federation)

^l THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

more..

Author keywords

Cold extremities; Flammer syndrome; Normal tension glaucoma; Optic disc hemorrhages; Predictive preventive personalized medicine; Primary vascular dysregulation; Retinal vein occlusion; Systemic hypotension; Tinnitus; Vasospasm

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; ENDOTHELIN 1; MAGNESIUM;

ASTROCYTE; AUTONOMIC DYSFUNCTION; BLOOD VESSEL PARAMETERS; CELL ACTIVATION; CIRCADIAN RHYTHM; CLINICAL EXAMINATION; DISEASE ASSOCIATION; DRUG SENSITIVITY; FLAMMER SYNDROME; HUMAN; HYPOTENSION; INTRAOCULAR HEMORRHAGE; LEAN BODY WEIGHT; LIFESTYLE MODIFICATION; LOW TENSION GLAUCOMA; MIGRAINE; NOCICEPTION; NUTRITIONAL SUPPORT; OCCUPATION; OCULAR BLOOD FLOW; OPTIC NERVE COMPARTMENTALIZATION; OXIDATIVE STRESS; PHYSICAL DISEASE BY BODY FUNCTION; PRIMARY VASCULAR DYSREGULATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RACE DIFFERENCE; RAYNAUD PHENOMENON; RETINAL VENOUS PRESSURE; RETINAL VESSEL STIFFNESS; REVIEW; SECONDARY VASCULAR DYSREGULATION; SENSORY SYSTEM PARAMETERS; SEX DIFFERENCE; SLEEP TIME; SYNDROME; THIRST; VASCULAR DISEASE; VENOUS PRESSURE; VISUAL FIELD DEFECT; WORK ENVIRONMENT;

EID: 84927737988     PISSN: 18785077     EISSN: 18785085     Source Type: Journal    
DOI: 10.1186/1878-5085-5-11     Document Type: Review

References (21)

1. Konieczka K, Fränkl S. Primäre vaskuläre Dysregulation und Glaukom [Primary vascular dysregulation and glaucoma]. Z Prakt Augenheilkd 2013, 34:207-215.
2. Konieczka K, Frankl S, Todorova MG, Henrich PB. Unstable oxygen supply and glaucoma. Klin Monbl Augenheilkd 2014, 231(2):121-126.
3. Konieczka K, Choi HJ, Koch S, Schoetzau A, Küenzi D, Kim DM. Frequency of symptoms and signs of primary vascular dysregulation in Swiss and Korean populations. Klin Monbl Augenheilkd 2014, 231(4):344-7.
4. Brähler E, Hoefert H-W. Lexikon der Modernen Krankheiten 2014, Berlin: Medizinisch Wissenschaftliche Verlagsgesellschaft.
5. Saner H, Wurbel H, Mahler F, Flammer J, Gasser P. Microvasculatory evaluation of vasospastic syndromes. Adv Exp Med Bio 1987, 220:215-218.
6. Flammer J, Konieczka K, Flammer AJ. The primary vascular dysregulation syndrome: implications for eye diseases. EPMA J 2013, 4(1):14.
7. Flammer J, Konieczka K, Bruno RM, Virdis A, Flammer AJ, Taddei S. The eye and the heart. Eur Heart J 2013, 34(17):1270-1278.
8. Flammer J. Glaukom. 3, überarbeitete Auflage ed 2009, Hans Huber Verlag: Bern.
9. Flammer J, Mozaffarieh M, Bebie H. Basic Sciences in Ophthalmology-Physics and Chemistry 2013, Heidelberg: Springer.
10. Mozaffarieh M, Flammer J. Pocket Reference to Ocular Blood Flow and Glaucomatous Optic Neuropathy 2009, Heidelberg: Springer.
11. Flammer J. The vascular concept of glaucoma. Surv Ophthalmol 1994, 38(Suppl):S3-S6.
12. Flammer J, Pache M, Resink T. Vasospasm, its role in the pathogenesis of diseases with particular reference to the eye. Prog Retin Eye Res 2001, 20(3):319-349.
13. Lekakis J, Abraham P, Balbarini A, Blann A, Boulanger CM, Cockcroft J, Cosentino F, Deanfield J, Gallino A, Ikonomidis I, Kremastinos D, Landmesser U, Protogerou A, Stefanadis C, Tousoulis D, Vassalli G, Vink H, Werner N, Wilkinson I, Vlachopoulos C. Methods for evaluating endothelial function: a position statement from the European Society of Cardiology Working Group on Peripheral Circulation. Eur J Cardiovasc Prev R 2011, 18(6):775-789.
14. Camici PG, Crea F. Coronary microvascular dysfunction. New Engl J Med 2007, 356(8):830-840.
15. Delaney Y, Walshe TE, O'Brien C. Vasospasm in glaucoma: clinical and laboratory aspects. Optometry Vision Sci 2006, 83(7):406-414.
16. Choi J, Jeong J, Cho HS, Kook MS. Effect of nocturnal blood pressure reduction on circadian fluctuation of mean ocular perfusion pressure: a risk factor for normal tension glaucoma. Inv Ophth Vis Sci 2006, 47(3):831-836.
17. Choi J, Kim KH, Jeong J, Cho HS, Lee CH, Kook MS. Circadian fluctuation of mean ocular perfusion pressure is a consistent risk factor for normal-tension glaucoma. Invest Ophth Vis Sci 2007, 48(1):104-111.
18. Choi J, Lee JR, Lee Y, Lee KS, Na JH, Han S, Kook MS. Relationship between 24-hour mean ocular perfusion pressure fluctuation and rate of paracentral visual field progression in normal-tension glaucoma. Invest Ophth Vis Sci 2013, 54(9):6150-6157.
19. Yeghiazaryan K, Flammer J, Golubnitschaja O. Predictive molecular profiling in blood of healthy vasospastic individuals: clue to targeted prevention as personalised medicine to effective costs. EPMA J 2010, 1(2):263-272.
20. Mozaffarieh M, Konieczka K, Flammer J. Calcium channel blockers: their use in normal tension glaucoma. Expert Rev Ophthalmol 2010, 5(5):9.
21. Golubnitschaja O, Yeghiazaryan K, Flammer J. Glaucomatous optic neuropathy: risk assessment and potential targets for effective prevention and treatments tailored to the patient. Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future 2013, 187-201. Dordrecht: Springer, Mandel S.